HONG KONG – The speed of approvals of biotechnology products in China remains a bone of contention for trade authorities in the U.S., even though "progress was made on some meaningful issues" in terms of market access within the second largest economy in the world in 2014. Read More
TOKYO – In the nearly 12 years since the completion of the Human Genome Project, next-generation sequencing methods have made genome sequencing both faster and cheaper, leading to massive increases in the numbers of individuals who can be sequenced. Projects have gone from the Human Genome Project, to the 1,000 Genomes Project, to the announcement last week of a 100,000 Genomes Project that plans to start recruiting patients in February 2015. (See BioWorld Today, Dec. 23, 2014.) Read More
HONG KONG – Chinese pharmaceutical regulators will begin 2015 by taking aim at improving supervision of shelf-life studies and storage of biological products in order to enhance consumer safety. Read More
SHANGHAI – China's Phagelux Inc. has made a deal with Delaware-registered Iveria Technologies Inc. to acquire several biodegradable polymer delivery systems for its phage technologies being developed for both human and agricultural uses. Read More
TOKYO – Even considering that much of the industry deals with life and death matters by the nature of the field, stem cells have long been a high drama part of biotechnology. And 2014 was no exception to that rule. Read More
Mylan Inc., of Pittsburgh, said its subsidiary in India, Mylan Laboratories Ltd., a manufacturer of antiretroviral (ARV) drugs, has been selected, through its South African-based subsidiary Mylan Ltd., as one of the leading suppliers of ARV medications to the South African National Department of Health for the period April 1, 2015, to March 31, 2018. Read More
